InVivo Therapeutics Holdings - 14 Year Stock Price History | NVIVQ
- The all-time high InVivo Therapeutics Holdings stock closing price was 425250.00 on July 22, 2013.
- The InVivo Therapeutics Holdings 52-week high stock price is 0.41, which is 10.8% above the current share price.
- The InVivo Therapeutics Holdings 52-week low stock price is 0.20, which is 45.9% below the current share price.
- The average InVivo Therapeutics Holdings stock price for the last 52 weeks is 0.37.
InVivo Therapeutics Holdings Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 0.4032 | 0.7900 | 0.7900 | 0.2100 | 0.3700 | -49.32% |
2023 | 1.3140 | 2.2900 | 2.6300 | 0.6000 | 0.7300 | -68.94% |
2022 | 5.6753 | 13.2500 | 13.5000 | 1.7600 | 2.3500 | -79.57% |
2021 | 19.8492 | 20.5000 | 44.5000 | 11.5000 | 11.5000 | -43.21% |
2020 | 58.7016 | 157.5000 | 255.0000 | 13.2500 | 20.2500 | -87.73% |
2019 | 682.8869 | 1222.5000 | 1282.5000 | 97.5000 | 165.0000 | -85.43% |
2018 | 4858.7151 | 17062.5000 | 17062.5000 | 1050.0000 | 1132.5000 | -92.16% |
2017 | 47184.2629 | 77812.5000 | 92812.5000 | 14250.0000 | 14437.5000 | -81.67% |
2016 | 109862.3631 | 136312.0000 | 184688.0000 | 68625.0000 | 78750.0000 | -41.67% |
2015 | 202994.0317 | 97500.0000 | 333375.0000 | 97500.0000 | 135000.0000 | 36.36% |
2014 | 100752.9762 | 168000.0000 | 195000.0000 | 37500.0000 | 99000.0000 | -42.61% |
2013 | 197354.1667 | 131250.0000 | 425250.0000 | 82500.0000 | 172500.0000 | 32.18% |
2012 | 159726.0000 | 209250.0000 | 213000.0000 | 96000.0000 | 130500.0000 | -36.73% |
2011 | 90693.4524 | 147000.0000 | 232500.0000 | 45000.0000 | 206250.0000 | 22.22% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.000B | $0.000B |
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $235.957B | 28.37 |
Boston Scientific (BSX) | United States | $147.560B | 36.94 |
Stryker (SYK) | United States | $144.011B | 30.11 |
EssilorLuxottica (ESLOY) | France | $127.141B | 0.00 |
Medtronic (MDT) | Ireland | $111.928B | 15.87 |
Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
Haleon (HLN) | United Kingdom | $48.926B | 27.87 |
ResMed (RMD) | United States | $36.560B | 27.46 |
Agilent Technologies (A) | United States | $33.258B | 21.68 |
GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.71 |
Terumo (TRUMY) | Japan | $26.680B | 34.65 |
Insulet (PODD) | United States | $21.438B | 84.15 |
Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.37 |
Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.60 |
Baxter (BAX) | United States | $15.713B | 11.73 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
Demant (WILYY) | Denmark | $9.377B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.54 |
Perrigo (PRGO) | Ireland | $3.664B | 9.29 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Haemonetics (HAE) | United States | $3.367B | 15.34 |
ICU Medical (ICUI) | United States | $3.250B | 23.96 |
Envista Holdings (NVST) | United States | $3.127B | 25.99 |
QuidelOrtho (QDEL) | United States | $1.954B | 13.44 |
LeMaitre Vascular (LMAT) | United States | $1.833B | 40.97 |
AtriCure (ATRC) | United States | $1.565B | 0.00 |
Acuren (TIC) | United States | $1.357B | 0.00 |
Neogen (NEOG) | United States | $1.200B | 15.36 |
AdaptHealth (AHCO) | United States | $1.161B | 11.78 |
Green Thumb Industries (GTBIF) | United States | $1.048B | 23.58 |
BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.970B | 12.40 |
Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
InMode (INMD) | Israel | $0.844B | 8.51 |
Evolus (EOLS) | United States | $0.640B | 0.00 |
CeriBell (CBLL) | United States | $0.624B | 0.00 |
Owens & Minor (OMI) | United States | $0.602B | 4.99 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
Valneva SE (VALN) | France | $0.510B | 0.00 |
Surmodics (SRDX) | United States | $0.417B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
SNDL (SNDL) | Canada | $0.339B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.337B | 12.41 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.329B | 58.50 |
Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
ZimVie (ZIMV) | United States | $0.253B | 11.52 |
Cerus (CERS) | United States | $0.252B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
Quanterix (QTRX) | United States | $0.235B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
Biote (BTMD) | United States | $0.207B | 5.82 |
Brainsway (BWAY) | Israel | $0.206B | 54.50 |
Omeros (OMER) | United States | $0.199B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
Organigram Global (OGI) | Canada | $0.187B | 0.00 |
High Tide (HITI) | Canada | $0.185B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.179B | 14.59 |
Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
Exagen (XGN) | United States | $0.152B | 0.00 |
Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
Jin Medical (ZJYL) | China | $0.107B | 0.00 |
MacroGenics (MGNX) | United States | $0.096B | 0.00 |
Fonar (FONR) | United States | $0.090B | 11.64 |
Veru (VERU) | United States | $0.090B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Agape ATP (ATPC) | $0.084B | 0.00 | |
TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Apyx Medical (APYX) | United States | $0.066B | 0.00 |
Zynex (ZYXI) | United States | $0.064B | 0.00 |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
Nephros (NEPH) | United States | $0.041B | 55.29 |
United-Guardian (UG) | United States | $0.037B | 12.90 |
Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
Safety Shot (SHOT) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
INLIF (INLF) | $0.012B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
Senestech (SNES) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |